Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP280934.RAv5vFYIO823WOyWvFhOPFLLOmuHanc9hrbyx7FAv2nvk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP280934.RAv5vFYIO823WOyWvFhOPFLLOmuHanc9hrbyx7FAv2nvk130_assertion type Assertion NP280934.RAv5vFYIO823WOyWvFhOPFLLOmuHanc9hrbyx7FAv2nvk130_head.
- NP280934.RAv5vFYIO823WOyWvFhOPFLLOmuHanc9hrbyx7FAv2nvk130_assertion description "[Hepatocyte growth factor (HGF) activator inhibitor type 1 (HAI-1) and type 2 (HAI-2) are new Kunitz-type serine protease inhibitors that were recently purified and cloned from the human stomach cancer cell line MKN45 as specific inhibitors against HGF activator.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP280934.RAv5vFYIO823WOyWvFhOPFLLOmuHanc9hrbyx7FAv2nvk130_provenance.
- NP280934.RAv5vFYIO823WOyWvFhOPFLLOmuHanc9hrbyx7FAv2nvk130_assertion evidence source_evidence_literature NP280934.RAv5vFYIO823WOyWvFhOPFLLOmuHanc9hrbyx7FAv2nvk130_provenance.
- NP280934.RAv5vFYIO823WOyWvFhOPFLLOmuHanc9hrbyx7FAv2nvk130_assertion SIO_000772 10762618 NP280934.RAv5vFYIO823WOyWvFhOPFLLOmuHanc9hrbyx7FAv2nvk130_provenance.
- NP280934.RAv5vFYIO823WOyWvFhOPFLLOmuHanc9hrbyx7FAv2nvk130_assertion wasDerivedFrom befree-2016 NP280934.RAv5vFYIO823WOyWvFhOPFLLOmuHanc9hrbyx7FAv2nvk130_provenance.
- NP280934.RAv5vFYIO823WOyWvFhOPFLLOmuHanc9hrbyx7FAv2nvk130_assertion wasGeneratedBy ECO_0000203 NP280934.RAv5vFYIO823WOyWvFhOPFLLOmuHanc9hrbyx7FAv2nvk130_provenance.